Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated mRNA Transport02:22

Regulated mRNA Transport

6.8K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.8K
Overview of Exosomes01:36

Overview of Exosomes

3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.

Alzheimer's research & therapy·2026
Same author

Humanized extracellular vesicles for efficient RNA delivery.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.

bioRxiv : the preprint server for biology·2026
Same author

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Massively parallel reporter assay for mapping gene-specific regulatory regions at single-nucleotide resolution.

eLife·2026
Same author

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.5K

Humanized Extracellular Vesicles for Efficient RNA Delivery.

Xiang Ma1,2, Sophia R Zhao1,2, Constance L Cepko1,2

  • 1Department of Genetics, Harvard Medical School, Boston, MA 02115.

Biorxiv : the Preprint Server for Biology
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel biological assay to optimize engineered extracellular vesicles (EVs) for RNA delivery. This new system, utilizing human-derived proteins, achieves efficient RNA delivery with reduced immunogenicity compared to existing methods.

Keywords:
EABREnveloped Protein Nanocages (EPNs)Epsin N-terminal homology (ENTH)Functional Titerscitramalyl-CoA lyase beta-like protein (CLYBL)

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.9K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.5K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.9K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.3K

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Vaccine Development

Background:

  • Engineered extracellular vesicles (EVs) are promising non-viral vectors for RNA delivery.
  • Enveloped protein nanocages (EPNs) enhance cargo loading but require better characterization and optimization methods.
  • Lack of single-unit activity assays hindered EPN optimization.

Purpose of the Study:

  • To develop a biological titration assay for engineered EVs.
  • To optimize EVs for efficient RNA delivery using a modular platform.
  • To create an EV-based system with reduced immunogenicity.

Main Methods:

  • Developed a biological titration assay for engineered EVs, adapted from infectious viral particle methods.
  • Utilized a modular platform to engineer EVs primarily from human protein components.
  • Incorporated chimeric proteins with domains from human epsin 1, CLYBL, and CEP55, plus a non-human peptide for RNA packaging.

Main Results:

  • Achieved efficient RNA delivery using the optimized EVs.
  • Functional titers were comparable to lentiviral vectors.
  • The resulting EV system demonstrated reduced immunogenicity compared to EPNs and retroviral VLPs.

Conclusions:

  • The developed biological assay enables effective optimization of engineered EVs.
  • The modular human-derived EV platform offers efficient and less immunogenic RNA delivery.
  • This system represents a significant advancement for RNA-based therapies and vaccines.